{
    "2018-05-30": [
        [
            {
                "time": "2018-05-01",
                "original_text": "Look at the Upside Potential of AstraZeneca Stock",
                "features": {
                    "keywords": [
                        "AstraZeneca",
                        "upside potential"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-06-05",
                "original_text": "Lilly to Participate in Jefferies Global Healthcare Conference",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Jefferies",
                        "Global Healthcare Conference"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-07-10",
                "original_text": "Allergan Recalls Taytulla Oral Contraceptives, Stock Down",
                "features": {
                    "keywords": [
                        "Allergan",
                        "recall",
                        "Taytulla",
                        "oral contraceptives",
                        "stock down"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-08-15",
                "original_text": "Top Analyst Reports for Chevron, Wells Fargo & Eli Lilly",
                "features": {
                    "keywords": [
                        "Chevron",
                        "Wells Fargo",
                        "Eli Lilly",
                        "analyst reports"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "energy",
                        "finance",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-09-20",
                "original_text": "Novo Nordisk's Oral Ozempic Positive in Diabetes Study",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "Oral Ozempic",
                        "Diabetes Study",
                        "positive"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-10-25",
                "original_text": "Novo Nordisk's Oral Ozempic Positive in Diabetes Study",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "Oral Ozempic",
                        "Diabetes Study",
                        "positive"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-11-30",
                "original_text": "A Look at Incyteâ€™s Product Portfolio in May",
                "features": {
                    "keywords": [
                        "Incyte",
                        "Product Portfolio"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}